Literature DB >> 23471640

Aerodynamic factors responsible for the deaggregation of carrier-free drug powders to form micrometer and submicrometer aerosols.

P Worth Longest1, Yoen-Ju Son, Landon Holbrook, Michael Hindle.   

Abstract

PURPOSE: To employ in vitro experiments combined with computational fluid dynamics (CFD) analysis to determine which aerodynamic factors were most responsible for deaggregating carrier-free powders to form micrometer and submicrometer aerosols from a capsule-based platform.
METHODS: Eight airflow passages were evaluated for deaggregation of the aerosol including a standard constricted tube, impaction surface, 2D mesh, inward radial jets, and newly proposed 3D grids and rod arrays. CFD simulations were implemented to evaluate existing and new aerodynamic factors for deaggregation and in vitro experiments were used to evaluate performance of each inhaler.
RESULTS: For the carrier-free formulation considered, turbulence was determined to be the primary deaggregation mechanism. A strong quantitative correlation was established between the mass median diameter (MMD) and newly proposed non-dimensional specific dissipation (NDSD) factor, which accounts for turbulent energy, inverse of the turbulent length scale, and exposure time. A 3D rod array design with unidirectional elements maximized NDSD and produced the best deaggregation with MMD<1 μm.
CONCLUSIONS: The new NDSD parameter can be used to develop highly effective dry powder inhalers like the 3D rod array that can efficiently produce submicrometer aerosols for next-generation respiratory drug delivery applications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23471640      PMCID: PMC3703624          DOI: 10.1007/s11095-013-1001-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  41 in total

1.  Dry powder inhaler device influence on carrier particle performance.

Authors:  Martin J Donovan; Sin Hyen Kim; Venkatramanan Raman; Hugh D Smyth
Journal:  J Pharm Sci       Date:  2011-11-17       Impact factor: 3.534

Review 2.  The use of computational approaches in inhaler development.

Authors:  William Wong; David F Fletcher; Daniela Traini; Hak-Kim Chan; Paul M Young
Journal:  Adv Drug Deliv Rev       Date:  2011-10-23       Impact factor: 15.470

Review 3.  Drug delivery devices: issues in drug development.

Authors:  Peter R Byron
Journal:  Proc Am Thorac Soc       Date:  2004

4.  Evaluation of the Respimat Soft Mist Inhaler using a concurrent CFD and in vitro approach.

Authors:  P Worth Longest; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2009-06       Impact factor: 2.849

5.  Particle aerosolisation and break-up in dry powder inhalers: evaluation and modelling of impaction effects for agglomerated systems.

Authors:  William Wong; David F Fletcher; Daniela Traini; Hak-kim Chan; John Crapper; Paul M Young
Journal:  J Pharm Sci       Date:  2011-03-01       Impact factor: 3.534

6.  Performance of combination drug and hygroscopic excipient submicrometer particles from a softmist inhaler in a characteristic model of the airways.

Authors:  P Worth Longest; Geng Tian; Xiang Li; Yoen-Ju Son; Michael Hindle
Journal:  Ann Biomed Eng       Date:  2012-07-21       Impact factor: 3.934

7.  Degree of throat deposition can explain the variability in lung deposition of inhaled drugs.

Authors:  Lars Borgström; Bo Olsson; Lars Thorsson
Journal:  J Aerosol Med       Date:  2006

8.  Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies.

Authors:  Jerry Z Yang; Anthony L Young; Po-Chang Chiang; Archie Thurston; Denise K Pretzer
Journal:  J Pharm Sci       Date:  2008-11       Impact factor: 3.534

9.  Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.

Authors:  Yoen-Ju Son; P Worth Longest; Michael Hindle
Journal:  Int J Pharm       Date:  2013-01-10       Impact factor: 5.875

10.  Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device.

Authors:  Michael Hindle; P Worth Longest
Journal:  J Pharm Pharmacol       Date:  2012-02-21       Impact factor: 3.765

View more
  24 in total

1.  Use of Computational Fluid Dynamics (CFD) Dispersion Parameters in the Development of a New DPI Actuated with Low Air Volumes.

Authors:  Worth Longest; Dale Farkas; Karl Bass; Michael Hindle
Journal:  Pharm Res       Date:  2019-05-28       Impact factor: 4.200

2.  Application of an inline dry powder inhaler to deliver high dose pharmaceutical aerosols during low flow nasal cannula therapy.

Authors:  Dale Farkas; Michael Hindle; P Worth Longest
Journal:  Int J Pharm       Date:  2018-05-05       Impact factor: 5.875

3.  Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth.

Authors:  Ross L Walenga; P Worth Longest; Anubhav Kaviratna; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-01-11       Impact factor: 2.849

4.  Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.

Authors:  Dale Farkas; Michael Hindle; Serena Bonasera; Karl Bass; Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-08-29       Impact factor: 2.849

5.  Development of high efficiency ventilation bag actuated dry powder inhalers.

Authors:  Srinivas R B Behara; P Worth Longest; Dale R Farkas; Michael Hindle
Journal:  Int J Pharm       Date:  2014-02-07       Impact factor: 5.875

6.  Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.

Authors:  P Worth Longest; Laleh Golshahi; Srinivas R B Behara; Geng Tian; Dale R Farkas; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-09-05       Impact factor: 2.849

Review 7.  Advances in device and formulation technologies for pulmonary drug delivery.

Authors:  John Gar Yan Chan; Jennifer Wong; Qi Tony Zhou; Sharon Shui Yee Leung; Hak-Kim Chan
Journal:  AAPS PharmSciTech       Date:  2014-04-12       Impact factor: 3.246

8.  Development of a New Inhaler for High-Efficiency Dispersion of Spray-Dried Powders Using Computational Fluid Dynamics (CFD) Modeling.

Authors:  Worth Longest; Dale Farkas
Journal:  AAPS J       Date:  2019-02-07       Impact factor: 4.009

9.  Validating Whole-Airway CFD Predictions of DPI Aerosol Deposition at Multiple Flow Rates.

Authors:  P Worth Longest; Geng Tian; Navvab Khajeh-Hosseini-Dalasm; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2016-04-15       Impact factor: 2.849

10.  Development of an Inline Dry Powder Inhaler That Requires Low Air Volume.

Authors:  Dale Farkas; Michael Hindle; P Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-12-20       Impact factor: 2.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.